At the lowest estimate, there are 35 million individuals infected with HIV and 80 million infected with<unk> <unk>  worldwide. With the significant global effect of each of these viruses, it is also important to note that there is a<unk> onsiderable overlap of HIV-positive individuals<unk> o-infected with HCV. In fact, 20% of HIV-positive individuals also have<unk> <unk> . This overlap is related to the<unk> ommon ways these viruses are spread, including<unk> ontaminated blood and bodily fluids such as semen and vaginal fluids. There are marked differences between groups affected by this<unk> o-infection. However, it is<unk> onsistent that HIV-positive individuals have a higher prevalence of<unk> <unk>  infection. Of those<unk> o-infected with HIV and HCV, almost 60% are intravenous drug users, a high risk group for mono-infection with HIV or HCV. Additionally, prevalence varies by geographical location with the highest prevalence of<unk> o-infection located in North Africa and the Middle East versus the lowest prevalence located in East Africa.
Hepatitis C and HIV coinfection
HIV superinfection
Tuberculosis in relation to HIV
Epstein–Barr virus infection
HPV-positive oropharyngeal cancer
Latent autoimmune diabetes in adults
Smoking in South Korea
History of coronavirus